RT Journal Article
SR Electronic
T1 CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP P203
DO 10.1186/2051-1426-3-S2-P203
VO 3
IS Suppl 2
A1 Morishima, Chihiro
A1 McNeel, Douglas G
A1 Patel, Manish R
A1 Kohrt, Holbrook E
A1 Waldmann, Thomas A
A1 Thompson, John A
A1 Conlon, Kevin C
A1 Sondel, Paul M
A1 Wakelee, Heather A
A1 Apodaca, Minjun C
A1 Fling, Steven P
A1 Disis, Mary L
A1 Creekmore, Stephen P
A1 Miller, Jeffrey S
YR 2015
UL http://jitc.bmj.com/content/3/Suppl_2/P203.abstract